Biomarin Pharmaceutical Inc at UBS Global Healthcare Virtual Conference Transcript
Good morning, and thank you, everyone, for joining the virtual UBS Global Healthcare Conference. So I'm Colin Bristow, one of the biotech analysts here. And it's my pleasure to have BioMarin here with me today. So speaking on behalf of the company, we have J.J. Bienaime, CEO of BioMarin; and Brian Mueller, CFO of BioMarin. So J.J., Brian, thank you for joining us today. Before we start, if anyone has a question, there is like a raise your hand function within this video system. But alternatively, feel free to e-mail me directly at [email protected], and I can try and field the question for you. So J.J., good morning. Congrats on the EMA accelerated assessment for Valrox, that was great timing. Thanks for organizing that for us. And I know you have some remarks. So right now, I'll hand it over to you. J.J.?
Thank you, Colin. We appreciate the opportunity to speak with you today. As you said, this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |